RPG Life Sciences Limited has informed the Exchange regarding 'Update in announcement filed on April 28, 2025'.
RPGLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
RPG Life Sciences has filed an update to its earlier announcement dated April 28, 2025, confirming the appointment of Mr. Yugal Sikri (DIN: 07576560) as a Non-Executive Non-Independent Director, effective May 1, 2025. Mr. Sikri brings over 35 years of pharma industry experience, with senior leadership stints at GlaxoSmithKline, Warner Lambert/Pfizer, Novartis, Ranbaxy, and RPG Life Sciences itself. He holds a Master of Pharmacy from IIT BHU, an MBA from Jamnalal Bajaj Institute, and management certificates from Thunderbird and Harvard Business School. He was previously on the RPG Life Sciences board for two years as an Independent Director and has served as Chairman of Pharmaceutical Management at NMIMS. The company confirmed he is not related to any other Director or KMP and is not debarred by SEBI from holding a directorship.
This is a routine governance update with no material financial impact. Shareholders may note the change in Mr. Sikri's status from Independent to Non-Executive Non-Independent Director, which slightly changes the board's composition and independence profile, but is unlikely to move the stock.